MESO Annual EBITDA
-$62.82 M
-$4.27 M-7.30%
30 June 2024
Summary:
As of January 23, 2025, MESO annual earnings before interest, taxes, depreciation & amortization is -$62.82 million, with the most recent change of -$4.27 million (-7.30%) on June 30, 2024. During the last 3 years, it has risen by +$21.83 million (+25.79%). MESO annual EBITDA is now -167.96% below its all-time high of $92.44 million, reached on June 30, 2011.MESO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MESO Quarterly EBITDA
N/A
30 June 2024
Summary:
MESO quarterly earnings before interest, taxes, depreciation & amortization is not available.MESO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MESO TTM EBITDA
N/A
30 June 2024
Summary:
MESO TTM earnings before interest, taxes, depreciation & amortization is not available.MESO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MESO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.3% | - | - |
| 3 y3 years | +25.8% | - | - |
| 5 y5 years | +25.7% | - | - |
MESO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.3% | +25.8% | ||||
| 5 y | 5-year | -7.3% | +25.8% | ||||
| alltime | all time | -168.0% | +30.0% |
Mesoblast Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$62.82 M(+7.3%) | - | - |
| June 2023 | -$58.55 M(-16.3%) | -$17.26 M(+36.2%) | -$59.78 M(+2.0%) |
| Mar 2023 | - | -$12.67 M(-31.8%) | -$58.62 M(-5.9%) |
| Dec 2022 | - | -$18.57 M(+64.6%) | -$62.27 M(-3.5%) |
| Sept 2022 | - | -$11.28 M(-29.9%) | -$64.56 M(-8.7%) |
| June 2022 | -$69.92 M(-17.4%) | -$16.10 M(-1.4%) | -$70.75 M(-7.9%) |
| Mar 2022 | - | -$16.32 M(-21.8%) | -$76.81 M(-6.4%) |
| Dec 2021 | - | -$20.86 M(+19.4%) | -$82.07 M(-0.9%) |
| Sept 2021 | - | -$17.47 M(-21.1%) | -$82.83 M(-5.6%) |
| June 2021 | -$84.65 M(+22.7%) | -$22.15 M(+2.7%) | -$87.73 M(-9.2%) |
| Mar 2021 | - | -$21.58 M(-0.2%) | -$96.63 M(+10.3%) |
| Dec 2020 | - | -$21.62 M(-3.3%) | -$87.59 M(-1.8%) |
| Sept 2020 | - | -$22.37 M(-28.0%) | -$89.22 M(+26.0%) |
| June 2020 | -$68.97 M(-18.4%) | -$31.06 M(+147.7%) | -$70.81 M(+19.3%) |
| Mar 2020 | - | -$12.54 M(-46.1%) | -$59.34 M(-15.6%) |
| Dec 2019 | - | -$23.25 M(+487.3%) | -$70.31 M(-1.7%) |
| Sept 2019 | - | -$3.96 M(-79.8%) | -$71.49 M(-15.4%) |
| June 2019 | -$84.53 M(+37.5%) | -$19.59 M(-16.6%) | -$84.54 M(-1.0%) |
| Mar 2019 | - | -$23.50 M(-3.8%) | -$85.39 M(-0.7%) |
| Dec 2018 | - | -$24.44 M(+43.7%) | -$86.03 M(+21.8%) |
| Sept 2018 | - | -$17.00 M(-16.9%) | -$70.63 M(+12.3%) |
| June 2018 | -$61.50 M | -$20.45 M(-15.3%) | -$62.92 M(-14.7%) |
| Mar 2018 | - | -$24.14 M(+167.1%) | -$73.72 M(+18.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | -$9.04 M(-2.7%) | -$62.46 M(-17.4%) |
| Sept 2017 | - | -$9.29 M(-70.3%) | -$75.62 M(-13.5%) |
| June 2017 | -$87.16 M(-1.7%) | -$31.26 M(+142.7%) | -$87.44 M(-9.5%) |
| Mar 2017 | - | -$12.88 M(-42.0%) | -$96.62 M(-5.1%) |
| Dec 2016 | - | -$22.20 M(+5.2%) | -$101.78 M(+2.3%) |
| Sept 2016 | - | -$21.11 M(-47.8%) | -$99.44 M(+12.2%) |
| June 2016 | -$88.63 M(-1.3%) | -$40.44 M(+124.3%) | -$88.63 M(+15.7%) |
| Mar 2016 | - | -$18.03 M(-9.2%) | -$76.61 M(-2.3%) |
| Dec 2015 | - | -$19.86 M(+92.9%) | -$78.38 M(-6.4%) |
| Sept 2015 | - | -$10.30 M(-63.8%) | -$83.74 M(+14.0%) |
| June 2015 | -$89.78 M(+27.5%) | -$28.42 M(+43.5%) | -$73.44 M(+63.1%) |
| Mar 2015 | - | -$19.80 M(-21.5%) | -$45.02 M(+78.5%) |
| Dec 2014 | - | -$25.22 M | -$25.22 M |
| June 2014 | -$70.43 M(+18.8%) | - | - |
| June 2013 | -$59.31 M(+22.7%) | - | - |
| June 2012 | -$48.34 M(-152.3%) | - | - |
| June 2011 | $92.44 M(-731.9%) | - | - |
| June 2010 | -$14.63 M(+46.1%) | - | - |
| June 2009 | -$10.01 M(+28.7%) | - | - |
| June 2008 | -$7.78 M(+12.0%) | - | - |
| June 2007 | -$6.95 M(-14.7%) | - | - |
| June 2006 | -$8.14 M(+505.9%) | - | - |
| June 2005 | -$1.34 M | - | - |
FAQ
- What is Mesoblast Limited annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Mesoblast Limited?
- What is Mesoblast Limited annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for Mesoblast Limited?
- What is the all time high TTM EBITDA for Mesoblast Limited?
What is Mesoblast Limited annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MESO is -$62.82 M
What is the all time high annual EBITDA for Mesoblast Limited?
Mesoblast Limited all-time high annual earnings before interest, taxes, depreciation & amortization is $92.44 M
What is Mesoblast Limited annual EBITDA year-on-year change?
Over the past year, MESO annual earnings before interest, taxes, depreciation & amortization has changed by -$4.27 M (-7.30%)
What is the all time high quarterly EBITDA for Mesoblast Limited?
Mesoblast Limited all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.96 M
What is the all time high TTM EBITDA for Mesoblast Limited?
Mesoblast Limited all-time high TTM earnings before interest, taxes, depreciation & amortization is -$25.22 M